Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts. more
Time Frame | BBLG | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.83% | -3.13% | -0.02% |
1-Month Return | -9.85% | -4.8% | 1.48% |
3-Month Return | 4.39% | -8.46% | 9.63% |
6-Month Return | -16.2% | -2.88% | 13.17% |
1-Year Return | -66% | 6.92% | 31.56% |
3-Year Return | -99.87% | 4.63% | 30.19% |
5-Year Return | -99.95% | 42.11% | 93.4% |
10-Year Return | -100% | 103.49% | 198.28% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 50.00 | - | - | - | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Profit | (50.00) | - | - | - | - | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 2.45M | 825.01K | 1.10M | 3.67M | 9.43M | [{"date":"2019-12-31","value":25.96,"profit":true},{"date":"2020-12-31","value":8.75,"profit":true},{"date":"2021-12-31","value":11.68,"profit":true},{"date":"2022-12-31","value":38.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (2.45M) | (825.01K) | (1.10M) | (3.67M) | (9.43M) | [{"date":"2019-12-31","value":-244743400,"profit":false},{"date":"2020-12-31","value":-82501400,"profit":false},{"date":"2021-12-31","value":-110147600,"profit":false},{"date":"2022-12-31","value":-366517300,"profit":false},{"date":"2023-12-31","value":-942830300,"profit":false}] |
Total Non-Operating Income/Expense | (1.95M) | (2.00M) | (1.31M) | 1.45M | (250.62K) | [{"date":"2019-12-31","value":-134.7,"profit":false},{"date":"2020-12-31","value":-137.78,"profit":false},{"date":"2021-12-31","value":-90.6,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.3,"profit":false}] |
Pre-Tax Income | (3.42M) | (1.82M) | (1.61M) | (1.48M) | (8.95M) | [{"date":"2019-12-31","value":-342320800,"profit":false},{"date":"2020-12-31","value":-182309000,"profit":false},{"date":"2021-12-31","value":-160908500,"profit":false},{"date":"2022-12-31","value":-148462000,"profit":false},{"date":"2023-12-31","value":-894873100,"profit":false}] |
Income Taxes | 1.60K | 1.60K | 1.60K | (2.18M) | (2.18M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.81,"profit":true},{"date":"2021-12-31","value":99.81,"profit":true},{"date":"2022-12-31","value":-136029.51,"profit":false},{"date":"2023-12-31","value":-136029.51,"profit":false}] |
Income After Taxes | (3.42M) | (1.82M) | (1.61M) | 695.93K | (6.77M) | [{"date":"2019-12-31","value":-492.12,"profit":false},{"date":"2020-12-31","value":-262.19,"profit":false},{"date":"2021-12-31","value":-231.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-972.53,"profit":false}] |
Income From Continuous Operations | (3.42M) | (1.82M) | (1.61M) | (1.48M) | (6.51M) | [{"date":"2019-12-31","value":-342481100,"profit":false},{"date":"2020-12-31","value":-182469000,"profit":false},{"date":"2021-12-31","value":-161068500,"profit":false},{"date":"2022-12-31","value":-148462000,"profit":false},{"date":"2023-12-31","value":-650538600,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (3.42M) | (1.82M) | (1.61M) | 695.93K | (8.95M) | [{"date":"2019-12-31","value":-492.12,"profit":false},{"date":"2020-12-31","value":-262.19,"profit":false},{"date":"2021-12-31","value":-231.44,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1285.86,"profit":false}] |
EPS (Diluted) | (0.47) | (121.89) | (0.34) | (0.42) | (10.46) | [{"date":"2019-12-31","value":-47,"profit":false},{"date":"2020-12-31","value":-12189.09,"profit":false},{"date":"2021-12-31","value":-34,"profit":false},{"date":"2022-12-31","value":-42,"profit":false},{"date":"2023-12-31","value":-1046,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BBLG | |
---|---|
Cash Ratio | 13.04 |
Current Ratio | 14.87 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BBLG | |
---|---|
ROA (LTM) | -57.25% |
ROE (LTM) | -119.03% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BBLG | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.07 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.93 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BBLG | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.81 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | 0.13 |
PEG | NM |
Bone Biologics Corp (BBLG) share price today is $1.165
Yes, Indians can buy shares of Bone Biologics Corp (BBLG) on Vested. To buy Bone Biologics Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BBLG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bone Biologics Corp (BBLG) via the Vested app. You can start investing in Bone Biologics Corp (BBLG) with a minimum investment of $1.
You can invest in shares of Bone Biologics Corp (BBLG) via Vested in three simple steps:
The 52-week high price of Bone Biologics Corp (BBLG) is $6.34. The 52-week low price of Bone Biologics Corp (BBLG) is $0.8.
The price-to-earnings (P/E) ratio of Bone Biologics Corp (BBLG) is
The price-to-book (P/B) ratio of Bone Biologics Corp (BBLG) is 0.81
The dividend yield of Bone Biologics Corp (BBLG) is 0.00%
The market capitalization of Bone Biologics Corp (BBLG) is $3.13M
The stock symbol (or ticker) of Bone Biologics Corp is BBLG